In a similar manner, CTL-associated antigen-4 (CTLA-4) on the surface of cancer cells can interact with CD80/CD86 costimulatory molecules on T cells, thereby blocking full T cell receptor activation by foreign antigen. Here, CTLA4 is linked to cancer.